Grant: Doctoral: Vanier Canada Graduate Scholarships
McGill University
$150,000.00
Estimating the Impact of the COVID-19 Pandemic on Ovarian Cancer Incidence, Treatment Volumes, Survival, and Inequalities in Canada
EF 2024-25
Résumé
Supervisors: Dr Talía Malagón & Dr Eduardo Franco, McGill University
Ovarian cancer is the deadliest gynecologic cancer worldwide, accounting for approximately 206,956 deaths each year. Often named the "silent killer", it frequently goes undiagnosed until advanced stages due to non-specific symptoms and a lack of reliable early detection methods. Consequently, early detection and timely treatment are critical for improving patient outcomes. The COVID-19 pandemic has further complicated the landscape of cancer care, disrupting essential services and making it even more challenging for ovarian cancer patients to receive the necessary care. Many experienced delays in diagnosis, surgery, chemotherapy, and radiation therapy, and were forced to rely on telemedicine for follow-up care, potentially worsening their overall prognosis.
The pandemic likely affected cancer care differently depending on patients' social and economic backgrounds. However, there is limited evidence regarding how these disruptions have influenced cancer outcomes across different socioeconomic groups in Quebec. As we move beyond the peak of the pandemic, understanding how these healthcare disruptions affected ovarian cancer management and the long-term consequences is crucial.
This study aims to explore how the pandemic influenced ovarian cancer diagnosis, treatment and survival in the short and long term, and to examine disparities in ovarian cancer-related outcomes among different social and economic groups, both before and after the pandemic.
The impact of this research will be far-reaching. The findings will not only shed light on how the pandemic has affected ovarian cancer care but also provide valuable insights for addressing other high-mortality cancers with comparable prognosis. This work will guide strategies to build a stronger healthcare system, ensuring it is better equipped to handle future health crises without compromising the quality of cancer care for Canadian women.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
517203
Name
Ndiaye Aissatou B
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Health systems / services
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Estimating the Impact of the COVID-19 Pandemic on Ovarian Cancer Incidence, Treatment Volumes, Survival, and Inequalities in Canada
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Health Inequalities; Healthcare System Resilience; Ovarian Cancer Management; Patients Prognosis
Abstract
Supervisors: Dr Talía Malagón & Dr Eduardo Franco, McGill University
Ovarian cancer is the deadliest gynecologic cancer worldwide, accounting for approximately 206,956 deaths each year. Often named the "silent killer", it frequently goes undiagnosed until advanced stages due to non-specific symptoms and a lack of reliable early detection methods. Consequently, early detection and timely treatment are critical for improving patient outcomes. The COVID-19 pandemic has further complicated the landscape of cancer care, disrupting essential services and making it even more challenging for ovarian cancer patients to receive the necessary care. Many experienced delays in diagnosis, surgery, chemotherapy, and radiation therapy, and were forced to rely on telemedicine for follow-up care, potentially worsening their overall prognosis.
The pandemic likely affected cancer care differently depending on patients' social and economic backgrounds. However, there is limited evidence regarding how these disruptions have influenced cancer outcomes across different socioeconomic groups in Quebec. As we move beyond the peak of the pandemic, understanding how these healthcare disruptions affected ovarian cancer management and the long-term consequences is crucial.
This study aims to explore how the pandemic influenced ovarian cancer diagnosis, treatment and survival in the short and long term, and to examine disparities in ovarian cancer-related outcomes among different social and economic groups, both before and after the pandemic.
The impact of this research will be far-reaching. The findings will not only shed light on how the pandemic has affected ovarian cancer care but also provide valuable insights for addressing other high-mortality cancers with comparable prognosis. This work will guide strategies to build a stronger healthcare system, ensuring it is better equipped to handle future health crises without compromising the quality of cancer care for Canadian women.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ndiaye, Aissatou B
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~